✦ LIBER ✦

PEN4: MEASURING THE REAL ANNUAL DIRECT COSTS OF DIABETES TYPE 2 PATIENTS IN GERMANY

✍ Scribed by A Goertz; A Spannheimer; U Reitberger; A Liebl; A Neiss

Book ID: 118612774
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 55 KB
Volume: 2
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)75868-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating the direct cost of Type 2 dia

Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost

✍ K. Athanasakis; M. Ollandezos; A. Angeli; A. Gregoriou; M. Geitona; J. Kyriopoul 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Direct Costs of Type 2 Diabetes in Mexic

Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector Perspective

✍ Chatzitheofilou, I.; Babineaux, S.M.; Ramírez-Gámez, J.; McDonell, A.; Vega-Hern 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMI

PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES IN THE UNITED STATES

✍ S. Curkendall; B. Zhang; K. Oh; S. Williams; M. Pollack; J.P. Graham 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Estimating the current and future costs

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

✍ N. Hex; C. Bartlett; D. Wright; M. Taylor; D. Varley 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Estimating the current and future costs

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

✍ N. Hex; C. Bartlett; D. Wright; M. Taylor; D. Varley 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Diabet. Med. 29, 855–862 (2012) ## Abstract **Aims** To estimate the current and future economic burdens of Type 1 and Type 2 diabetes in the UK. **Methods** A top‐down approach was used to estimate costs for 2010/2011 from aggregated data sets and literature. Prevalence and population data were

PDB35 LOWER TREATMENT COSTS WITH INSULIN

PDB35 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE-2 DIABETES PATIENTS ON BASAL-BOLUS THERAPY UNDER REAL WORLD CONDITIONS IN GERMANY

✍ R Bierwirth; T Kohlmann; FW Dippel; W Landgraf; R Holle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB